Orthofix Medical Valuation Multiples

Orthofix Medical Overview

About Orthofix Medical

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

Founded

1987

HQ

Employees

1.6K

Website

orthofix.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $832M

EBITDA: $87M

EV

$607M

Valuation Multiples

Multiples.vc

Start free trial

Orthofix Medical Financials

Orthofix Medical reported last 12-month revenue of $832M and EBITDA of $87M.

In the same LTM period, Orthofix Medical generated $586M in gross profit, $87M in EBITDA, and $26M in net income.

Orthofix Medical P&L

In the most recent fiscal year, Orthofix Medical reported revenue of $822M and EBITDA of $83M.

Orthofix Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

Orthofix Medical Stock Performance

Orthofix Medical has current market cap of $511M, and enterprise value of $607M.

Orthofix Medical's stock price is $12.72.

Orthofix Medical Valuation Multiples

Orthofix Medical trades at 0.7x EV/Revenue multiple, and 7.0x EV/EBITDA.

Orthofix Medical Financial Valuation Multiples

As of April 19, 2026, Orthofix Medical has market cap of $511M and EV of $607M.

Equity research analysts estimate Orthofix Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Orthofix Medical has a P/E ratio of 19.4x.

Orthofix Medical Margins & Growth Rates

Orthofix Medical's revenue in the last 12 month grew by 5%.

Orthofix Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Orthofix Medical's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Orthofix Medical's rule of X is 21% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Orthofix Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Orthofix Medical M&A Activity

Orthofix Medical acquired XXX companies to date.

Last acquisition by Orthofix Medical was on XXXXXXXX, XXXXX. Orthofix Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Orthofix Medical Investment Activity

Orthofix Medical invested in XXX companies to date.

Orthofix Medical made its latest investment on XXXXXXXX, XXXXX. Orthofix Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).